Neurotoxicity Testing Services
General neurotoxicity assessment for drug candidates
ServiceActive
Key Facts
Indication
General neurotoxicity assessment for drug candidates
Phase
Service
Status
Active
Company
About Cellectricon
Cellectricon operates as a specialized neuroscience drug discovery services provider, leveraging a proprietary in vitro technology platform to offer end-to-end research solutions. The company has recently expanded its service portfolio with dedicated Neurotoxicity Testing modules and is actively forming strategic partnerships to strengthen its global presence, particularly in Japan. As a private, revenue-generating CRO, Cellectricon's business model is built on collaborative, fee-for-service engagements aimed at helping clients identify novel targets and compounds while assessing safety liabilities earlier in the R&D process.
View full company profile